4-Ethyl-1H-pyrazole → (1R,2S,3R,5S)-3-[2-Chloro 6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-(4-ethyl-pyrazol-1-yl)-cyclopentane-1,2-diol

HRID 215854Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 215854
[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][N:8]2[CH:11]2[CH2:15][CH:14]([N:16]3N=N[C:18]([CH2:21][CH3:22])=[N:17]3)[CH:13]([OH:23])[CH:12]2[OH:24])=[C:4]([NH:25][CH2:26][CH:27]([C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)[C:28]2[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=2)[N:3]=1.[CH2:40](C1C=NNC=1)[CH3:41]>>[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][N:8]2[C@@H:11]2[CH2:15][C@H:14]([N:16]3[CH:22]=[C:21]([CH2:40][CH3:41])[CH:18]=[N:17]3)[C@@H:13]([OH:23])[C@H:12]2[OH:24])=[C:4]([NH:25][CH2:26][CH:27]([C:28]2[CH:29]=[CH:30][CH:31]=[CH:32][CH:33]=2)[C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)[N:3]=1

Komponenten

3

Edukt 2

HCID 129332744-Ethyl-1H-pyrazoleHCID 866436693-[2-Chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-(5-ethyl-tetrazol-2-yl)-cyclopentane-1,2-diol

Produkt 1

HCID 86622836(1R,2S,3R,5S)-3-[2-Chloro 6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-(4-ethyl-pyrazol-1-yl)-cyclopentane-1,2-diol

Versuchsvorschrift

The title compound is prepared analogously to 1R,2S,3R,5S)-3-[2-chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-(5-ethyl-tetrazol-2-yl)-cyclopentane-1,2-diol (Intermediate EA) by replacing 5-ethyltetrazole with 4-ethyl-1H-pyrazole. MS (ES+) m/e 544.23 (MH+)

Quellen und Nachweise

ORD-Eintrag
ord-b49bd5987a02491d9635a121d6a92fb3
Quelldatensatz
uspto-grants-2012_06
Patentnummer
US08193164B2

Notizen zur Reaktion

Wird geladen…